178 related articles for article (PubMed ID: 35780453)
1. ASO Author Reflections: Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors-A Single Operation is Feasible in Most Patients.
Gudmundsdottir H; Halfdanarson TR; Cleary SP
Ann Surg Oncol; 2022 Oct; 29(11):6958-6959. PubMed ID: 35780453
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Reconsidering Resection for Patients with Poorly Differentiated Pancreatic Neuroendocrine Carcinoma.
Kaslow SR; Correa-Gallego C
Ann Surg Oncol; 2022 Jun; 29(6):3532-3533. PubMed ID: 35220501
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Refining the Surgical Management of Pancreatic Neuroendocrine Tumors.
Cloyd JM; Poultsides GA
Ann Surg Oncol; 2021 Feb; 28(2):1050-1051. PubMed ID: 32974698
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Preoperative Malignant Risk Assessment for Small (≤ 20 mm) Nonfunctioning Pancreatic Neuroendocrine Tumors.
Nanno Y; Toyama H
Ann Surg Oncol; 2023 Jun; 30(6):3501-3502. PubMed ID: 36765011
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Trends in the Number of Lymph Nodes Evaluated Following Resection of Pancreatic Neuroendocrine Tumors-An Increasing Adoption of the AJCC Guidelines?
Sahara K; Tsilimigras DI; Pawlik TM
Ann Surg Oncol; 2020 Apr; 27(4):1213-1214. PubMed ID: 31832917
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: Lymph Node Metastasis in Pancreatic Neuroendocrine Tumor.
Tanaka M; Hackert T
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):863-864. PubMed ID: 32720037
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Uninsurance is Associated with Worse Outcomes Following Resection for Gastro-Entero-Pancreatic Neuroendocrine Tumors.
Marincola Smith P; Baechle JJ; Idrees K
Ann Surg Oncol; 2020 Sep; 27(9):3154-3155. PubMed ID: 32189167
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: Elevated Preoperative Specific Growth Rate is Associated with Shortened Survival After Resection for Pancreatic Neuroendocrine Tumors.
Baechle JJ; Marincola Smith P; Idrees K
Ann Surg Oncol; 2020 Oct; 27(10):3924-3925. PubMed ID: 32468347
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: Patient-Reported Quality of Life in Patients with Neuroendocrine Tumors Following Surgical Resection.
Rosowicz A; Bangla VG; Divino CM
Ann Surg Oncol; 2023 Oct; 30(11):6786. PubMed ID: 37394669
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Pancreatic Neuroendocrine Tumor Recurrence and Survival Predicted by Ki67.
Nieveen van Dijkum EJM
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):531-532. PubMed ID: 30519760
[No Abstract] [Full Text] [Related]
11. Surgical Management of Pancreatic Neuroendocrine Tumors.
Vaghaiwalla T; Keutgen XM
Surg Oncol Clin N Am; 2020 Apr; 29(2):243-252. PubMed ID: 32151358
[TBL] [Abstract][Full Text] [Related]
12. ASO Author Reflections: Pancreatic Resection Margins-Chasing Moons.
Shah MM; Datta J; Merchant NB; Kooby DA
Ann Surg Oncol; 2022 Mar; 29(3):1551-1552. PubMed ID: 34997421
[No Abstract] [Full Text] [Related]
13. Surgical Management of Pancreatic Neuroendocrine Tumors.
Clancy TE
Hematol Oncol Clin North Am; 2016 Feb; 30(1):103-18. PubMed ID: 26614371
[TBL] [Abstract][Full Text] [Related]
14. The Pancreas as a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine Tumors.
Scott AT; Pelletier D; Maxwell JE; Sherman SK; Keck KJ; Li G; Dillon JS; O'Dorisio TM; Bellizzi AM; Howe JR
Ann Surg Oncol; 2019 Aug; 26(8):2525-2532. PubMed ID: 31011904
[TBL] [Abstract][Full Text] [Related]
15. [Importance of surgery in distant metastatic pancreatic neuroendocrine neoplasms].
Billmann F; Nießen A; Hackert T
Chirurgie (Heidelb); 2022 Aug; 93(8):758-764. PubMed ID: 35403909
[TBL] [Abstract][Full Text] [Related]
16. ASO Author Reflection: Risk of Recurrence After Radical Resection in Entero-Pancreatic Neuroendocrine Tumors.
Merola E
Ann Surg Oncol; 2022 Sep; 29(9):5578-5579. PubMed ID: 35581515
[No Abstract] [Full Text] [Related]
17. Laparoscopic enucleation of a nonfunctioning neuroendocrine tumor at the head of the pancreas.
Singh N; Lo CY; Chan WF
JSLS; 2006; 10(2):259-62. PubMed ID: 16882434
[TBL] [Abstract][Full Text] [Related]
18. [SURGICAL TREATMENT OF METASTATIC NON—FUNCTIONING NEUROENDOCRINE TUMORS OF THE PANCREAS].
Shkarban VP
Klin Khir; 2016; (7):5-7. PubMed ID: 30256557
[TBL] [Abstract][Full Text] [Related]
19. [Surgical treatment of gastroentero-pancreatic neuroendocrine tumor].
Ohtsuka T; Takahata S; Ueda J; Ueki T; Nagai E; Mizumoto K; Shimizu S; Tanaka M
Gan To Kagaku Ryoho; 2013 Jul; 40(7):843-6. PubMed ID: 23863724
[TBL] [Abstract][Full Text] [Related]
20. Comparative Clinical Analysis of Gastroenteropancreatic Neuroendocrine Carcinomas with Liver Metastasis and Primary Hepatic Neuroendocrine Carcinomas.
Qiu MJ; Chen YB; Bi NR; Yang SL; He XX; Xiong ZF
Dis Markers; 2018; 2018():9191639. PubMed ID: 30416612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
